Skip to main content
Log in

Extraneuronal uptake of noradrenaline in human tissue (uptake2)

  • Originals
  • Published:
Heart and Vessels Aims and scope Submit manuscript

Summary

The neurotransmitter, noradrenaline, is inactivated by active transport out of the synaptic cleft, either back into the adrenergic neurons (uptake1) or into extraneuronal cells (uptake2). Although experimental models clearly demonstrate uptake2 in various animal tissues, there are few reports of studies that demonstrate uptake2 in human tissue. Furthermore, uptake2 has never been described in human heart tissue. We demonstrated a reduction of3H-noradrenaline uptake in human atrial and venous tissue and in rat atrial and ventricular tissue by O-methylisoprenaline — a known inhibitor of uptake2. These results indicate that uptake2, as has been described in previous experimental models, does exist in humans and further, the results emphasize the importance of uptake2, since about 50% of exogenous noradrenaline is inactivated by uptake2 in the rat heart.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Graefe K-H, Bönisch H (1988) The transport of amines across the axonal membranes of noradrenergic and dopaminergic neurones. In: Trendelenburg U, Weiner N (eds) Catecholamines I (Handbook Exp Pharmacol, vol 90). Springer, Berlin Heidelberg New York London Paris Tokyo, pp 193–245

    Google Scholar 

  2. Iversen LL (1965) The uptake of catecholamines at high perfusion concentrations in the rat isolated heart: A novel catecholamine uptake process. Br J Pharmacol 25:18–33

    Google Scholar 

  3. Gillespie JS, Towart R (1973) Uptake kinetics and ion requirements for extraneuronal uptake of noradrenaline by arterial smooth muscle and collagen. Br J Pharmacol 47:556–567

    Google Scholar 

  4. Trendelenburg U (1988) The extraneuronal uptake and metabolism of catecholamines. In: Trendelenburg U, Weiner N (eds) Catecholamines I (Handbook Exp Pharmacol, vol 90/1). Springer, Berlin Heidelberg New York London Tokyo, pp 279–319

    Google Scholar 

  5. Burnstock G, McCulloch MW, Story DF, Wright ME (1972) Factors affecting the extraneuronal inactivation of noradrenaline in cardiac and smooth muscle. Br J Pharmacol 46:243–253

    Google Scholar 

  6. Chang PC, Krogt van der JA, Brummelen van P (1987) Demonstration of neuronal and extraneuronal uptake of circulating norepinephrine in the forearm. Hypertension 9:647–653

    Google Scholar 

  7. Schömig E, Schönfeld C-L (1990) Extraneuronal noradrenaline transport (uptake2) in a human cell line (Caki-1 cells). Naunyn Schmiedebergs Arch Pharmacol 341:404–410

    Google Scholar 

  8. Schömig E, Babin-Ebell J, Russ H, Trendelenburg U (1992) The force driving the extraneuronal transport mechanism for catecholamines (uptake2). Naunyn Schmiedebergs Arch Pharmacol 345(4):437–443

    Google Scholar 

  9. Fiebig ER, Trendelenburg U (1978) The neuronal and extraneuronal uptake and metabolism of3H-(−)-noradrenaline in the perfused rat heart. Naunyn Schmiedebergs Arch Pharmacol 303:21–35

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Babin-Ebell, J., Gliese, M. Extraneuronal uptake of noradrenaline in human tissue (uptake2). Heart Vessels 10, 151–153 (1995). https://doi.org/10.1007/BF01744482

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01744482

Key words

Navigation